Skip to content

Engineer Perfect Antibodies at the Speed of AI

From target to validated antibody candidate in months — not years. Closed-loop AI design, automated wet-lab and cryo-EM, working as one system.

View platform Talk to us
HKTDC Start-up Express International 2025 — Top 10 Winner (Health-tech)

How it works

AI design, wet-lab, and cryo-EM — one closed loop.

Each campaign sharpens the next. Generative design feeds the auto-lab; the auto-lab feeds cryo-EM; cryo-EM feeds the model.

Evidence

Outcomes, measured.

WITH abYcloud

8× FASTER
~0 mo

Target → validated candidate

INDUSTRY BASELINELEGACY
~0 mo

Target → validated candidate

WITH abYcloud

4× FASTER
~0 wk

Per optimisation round

BEFORELEGACY
~0 wk

Per optimisation round

WITH abYcloud

>70% CUT
>0%

Cryo-EM cost cut

LEGACY SPENDLEGACY
0%

Cryo-EM structure cost

2 850+citations on foundational work · NeurIPS 2024 + mAbs 2024See Research →
See the engagements behind these numbers →

Hong Kong · GBA

A UK origin. A Hong Kong landing. A GBA reach.

abYcloud is a UK-origin company that has landed operationally in Hong Kong. HK is our R&D orchestration and commercialisation hub — the international interface between UK research and Greater Bay Area execution. We are not here for manufacturing; we are here because Hong Kong is the structural fit for cross-border antibody therapeutic development.

“Trade the execution, not just the idea.”

Three things make this work.

  • HK commercial gravity

    Paying R&D engagements with HK-based pharma and enterprise-AI partners, including signed commercial collaborations.

  • HK academic & clinical traction

    Clinical-translational pilots with a major HK university hospital, including an agentic-SaaS prototype that automates patient-data analysis for clinical-research teams.

  • HK I&T ecosystem plug-in

    Operating from the HKSTP InnoCentre seat; participating in joint funding-programme applications; HKTDC Start-up Express International 2025 — Top 10 Winner (Health-tech).

A unique HK data asset

Underpinning the strategy: the Hospital Authority's CDARS (Clinical Data Analysis and Reporting System) holds 30+ years of longitudinal records.

30+
Years of longitudinal records
4.5B+
Patient-data entries
7M+
Patients covered
80%+
of HK population

<5%of this clinical data is currently used for drug R&D — the gap our HK landing is built to fill.

Network · UK ↔ HK ↔ Mainland China

Building globe…
UNITED KINGDOM
GREATER BAY
YANGTZE DELTA
  • Operations HQ
  • Partner site
Read the HK story

Talk to us about embedding abYcloud in your pipeline.

15 minutes, no setup. We'll show how the closed loop maps to your campaign.

See the research